Bratton Capital Management, L.P., 10% Owner, Director at Aquestive Therapeutics, Inc. (AQST), bought 165,000 shares at $15.00 ($2.5M) on 2018-07-24, disclosed to the SEC on 2018-07-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.